Stocks and Investing Stocks and Investing
Fri, April 28, 2023
Thu, April 27, 2023

Joseph Pantginis Maintained (VKTX) at Strong Buy with Increased Target to $33 on, Apr 27th, 2023


Published on 2024-10-28 03:07:35 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Viking Therapeutics, Inc." (VKTX) at Strong Buy with Increased Target from $21 to $33 on, Apr 27th, 2023.

Joseph has made no other calls on VKTX in the last 4 months.



There are 6 other peers that have a rating on VKTX. Out of the 6 peers that are also analyzing VKTX, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Joseph


  • Anthony Vendetti of "Maxim Group" Maintained at Strong Buy with Increased Target to $25 on, Wednesday, March 29th, 2023
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $32 on, Wednesday, March 29th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $31 on, Wednesday, March 29th, 2023
  • Matt Koranda of "Roth MKM" Maintained at Strong Buy with Increased Target to $19 on, Wednesday, March 29th, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Buy with Increased Target to $35 on, Wednesday, March 29th, 2023
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $25 on, Tuesday, March 28th, 2023

Contributing Sources